Condition (MeSH)
Eyelid Neoplasms
ClinicalTrials.gov lists 7 trials for Eyelid Neoplasms or a narrower condition beneath it. Alpha Tau Medical LTD. has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Eyelid Neoplasms itself; the rest are tagged with a narrower condition beneath it.
When did Eyelid Neoplasms trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2022 | 3 |
| 2021 | 1 |
| 2020 | 2 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Eyelid Neoplasms trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
| Not applicable | 3 |
| Observational | 3 |
How many Eyelid Neoplasms trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 4 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Eyelid Neoplasms trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alpha Tau Medical LTD. | 1 |
Which publications cover Eyelid Neoplasms? (23)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Sebaceous Carcinoma of the Eyelid: Proposed Nomenclature for Multifocal and Multicentric Disease. | Ophthalmic plastic and reconstructive surgery | 2023 | Yes |
| Management of recurrent sebaceous gland carcinoma. | Eye (London, England) | 2020 | Yes |
| Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancy: A Report by the American Academy of Ophthalmology. | Ophthalmology | 2020 | Yes |
| Current review of sebaceous cell carcinoma. | Current opinion in ophthalmology | 2018 | Yes |
| Carbon dioxide laser combined with botulinum toxin A for patients with periorbital syringomas. | Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology | 2016 | Yes |
Showing 5 of 23 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.